Reata Pharmaceuticals

United States
Brookdale, South Carolina, United States, 75063

Company profile

Reata Pharmaceuticals company profile

Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases. It offers antioxidant and inflammation-modulating drugs, as well as drugs that correct protein misfolding. The company also develops drugs for the treatment of renal, cardiovascular, and autoimmune diseases. The company was formerly known as Reata Discovery, Inc. and changed its name to Reata Pharmaceuticals, Inc. in May 2005.

Business identity

Contact email
[email protected]
Phone number
972-865-2219
Operating status
Active
Company type
For Profit
Employee range
251-500 employees
Revenue range
$0+
Founded
2002-01-01, Year

Headquarters

Postal code
75063
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
16
Total equity funding
$1.7B
Last funding
Post IPO Debt / $275M / 2023-05-10
Last equity funding
Post IPO Equity / $350M
Investors
10
Lead investors
7
Founders
1
Articles
109
Exited on
2016-05-26

Founders and investors

Founders

Warren Huff

Lead investors

Blackstone Life SciencesCPMGNovo HoldingsOjai GoliadOxford Finance LLCSilicon Valley BankStartech Early Ventures

Investors

Blackstone Life SciencesNovo HoldingsOxford Finance LLCSilicon Valley BankThe University of Texas at Austin